Skip to content

Drug interactions

Lapatinib + Palbociclib

Severity: Moderate

Lapatinib and Palbociclib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lapatinib is a CYP3A4 inhibitor and may raise palbociclib exposure. This may increase neutropenia and other adverse effects.

What this interaction means in plain words

Lapatinib and Palbociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lapatinib belongs to Oncology; Palbociclib belongs to Oncology.

Evidence level: Low

Why it happens

Lapatinib inhibits CYP3A4-mediated palbociclib metabolism.

What to do

Monitor complete blood counts frequently and reduce or interrupt palbociclib for neutropenia.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lapatinib and Palbociclib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lapatinib with Palbociclib?

MediHelp rates the interaction as moderate. Lapatinib and Palbociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lapatinib is a CYP3A4 inhibitor and may raise palbociclib exposure. This may increase neutropenia and other adverse effects.

How serious is the interaction between Lapatinib and Palbociclib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts frequently and reduce or interrupt palbociclib for neutropenia.

What other medicines interact with Lapatinib?

MediHelp also lists interactions of Lapatinib with, for example, Dofetilide, Ibutilide, Pimozide. The full list is on the Lapatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in